1.
Br J Nutr
; 128(4): 778-779, 2022 08 28.
Artículo
en Inglés
| MEDLINE
| ID: mdl-34530940
RESUMEN
Sickle cell disease is associated with lower selenium levels, and the serum selenium level is inversely associated with haemolysis in SCD. The SCD population is more vulnerable to adverse COVID-19 outcomes. SARS-CoV-2 infection lowers the serum selenium level and this is associated with severity of COVID-19. Selenium supplementation is proposed to improve COVID-19 outcomes in the sickle cell disease population.